7min chapter

Blood Cancer Talks cover image

Episode 35. Bispecific Antibodies in Lymphoma with Dr. Michael Dickinson

Blood Cancer Talks

CHAPTER

Toxicity and Toxicity Management in Bispecific Antibodies

This chapter discusses the toxicity and management of cytokine release syndrome (CRS) associated with bispecific antibodies in lymphoma, comparing it with CRS after CAR T cells. It explores the variability in CRS rates and manifestations among different bispecific antibodies, and the role of pharmacokinetics, dose, and disease characteristics in CRS occurrence.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode